Nous Funding

London start-up Nous has raised $17 million, led by Heartcore Capital and Mosaic Ventures, to take its household bills AI agent beyond the UK.

Basel biotech Nouscom raised €120 million ($135 million) in a Series D on October 19, 2026 to take its NOUS-209 vaccine for Lynch syndrome carriers into a larger trial.